Kotak Mahindra Mutual Fund launches Kotak Nifty Pharma Index Fund

NFO
Nov 16, 2026 by Advisorkhoj Team | NFO | 0 Downloaded

NFO period: 16th Nov - 30rd Nov, 2026

Highlights of the NFO:

  • Scheme type - An open-ended scheme replicating/tracking the Nifty Pharma Index

  • Investment objective - The investment objective of the scheme is to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking errors. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.

  • Product suitability - This product is suitable for investors who are seeking to generate long term capital growth. Return that corresponds to the performance of Nifty Pharma Index subject to tracking error.

  • Minimum Application Amount - Rs.1000/- and any amount thereafter.

  • Plan/ Options available - Regular plan & Direct plan having Growth Option and Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of Income Distribution cum capital withdrawal option and Reinvestment of Income Distribution cum capital withdrawal option).

  • Fund Managers - Mr. Satish Dondapati, Mr. Jeetu Valechha Sonar & Mr. Abhishek Bisen

  • Benchmark - Nifty Pharma Index (TRI)

(Mutual Fund investments are subject to market risks, read all scheme related documents carefully.)

Locate Kotak Mahindra Mutual Fund Advisors in your city
Feedback
Notification